Gallbladder disease, including cholelithiasis and cholecystitis, may occur with rapid weight loss
The 2022 List was approved by WADAs Executive Committee (ExCo) during its meeting on 14 September 2021 and was first published on 30 September 2021
Appl Environ Microbiol 61(9):32023207
Regular review of long-term use is advised, along with lifestyle advice for bone health
Uncontrolled or Severe Mental Health Conditions GLP-1 medications can affect appetite, energy levels, and mood, creating complexity for individuals with active depression, bipolar disorder, or eating disorders
Hypothalamic-ovarian axis and adiposity relationship in polycystic ovary syndrome: physiopathology and therapeutic options for the management of metabolic and inflammatory aspects